Astrana Health (ASTH) Competitors

$47.64

-0.22 (-0.46%)

(As of 09/6/2024 ET)

ASTH vs. ULS, RDDT, STN, CART, GLOB, HQY, BILI, ETSY, QXO, and TNET

Should you be buying Astrana Health stock or one of its competitors? The main competitors of Astrana Health include UL Solutions (ULS), Reddit (RDDT), Stantec (STN), Maplebear (CART), Globant (GLOB), HealthEquity (HQY), Bilibili (BILI), Etsy (ETSY), QXO (QXO), and TriNet Group (TNET). These companies are all part of the "business services" industry.

Astrana Health vs.

Astrana Health (NASDAQ:ASTH) and UL Solutions (NYSE:ULS) are both mid-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, valuation, institutional ownership, earnings, analyst recommendations, community ranking, risk, media sentiment and profitability.

: In the previous week, UL Solutions had 3 more articles in the media than Astrana Health. MarketBeat recorded 6 mentions for UL Solutions and 3 mentions for Astrana Health. UL Solutions' average media sentiment score of 1.14 beat Astrana Health's score of 0.98 indicating that UL Solutions is being referred to more favorably in the news media.
Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Astrana Health
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
UL Solutions
3 Very Positive mention(s)
3 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
: Astrana Health has a net margin of 4.30% compared to UL Solutions' net margin of 0.00%. Astrana Health's return on equity of 10.71% beat UL Solutions' return on equity.
Company Net Margins Return on Equity Return on Assets
Astrana Health 4.30% 10.71% 6.10%
UL Solutions N/A N/A N/A
: Astrana Health presently has a consensus target price of $59.00, suggesting a potential upside of 23.85%. UL Solutions has a consensus target price of $43.90, suggesting a potential downside of 9.63%. Given Astrana Health's stronger consensus rating and higher possible upside, analysts plainly believe Astrana Health is more favorable than UL Solutions.
Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Astrana Health
0 Sell rating(s)
0 Hold rating(s)

4 Buy rating(s)

1 Strong Buy rating(s)
3.20
UL Solutions
0 Sell rating(s)

4 Hold rating(s)

8 Buy rating(s)

0 Strong Buy rating(s)
2.67
: 52.8% of Astrana Health shares are held by institutional investors. 8.5% of Astrana Health shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.
: UL Solutions received 6 more outperform votes than Astrana Health when rated by MarketBeat users. However, 88.89% of users gave Astrana Health an outperform vote while only 70.00% of users gave UL Solutions an outperform vote.
Company Underperform Outperform
Astrana Health Outperform Votes
8
88.89%
Underperform Votes
1
11.11%
UL Solutions Outperform Votes
14
70.00%
Underperform Votes
6
30.00%
: UL Solutions has higher revenue and earnings than Astrana Health.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Astrana Health $1.59B 1.68 $60.72M $1.32 36.09
UL Solutions $2.68B 3.63 $260M N/A N/A

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Astrana Health	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
UL Solutions	3 Very Positive mention(s)	3 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Company	Net Margins	Return on Equity	Return on Assets
Astrana Health	4.30%	10.71%	6.10%
UL Solutions	N/A	N/A	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Astrana Health	0 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	3.20
UL Solutions	0 Sell rating(s)	4 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.67

Company	Underperform	Outperform
Astrana Health	Outperform Votes 8 88.89%	Underperform Votes 1 11.11%
UL Solutions	Outperform Votes 14 70.00%	Underperform Votes 6 30.00%

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Astrana Health	$1.59B	1.68	$60.72M	$1.32	36.09
UL Solutions	$2.68B	3.63	$260M	N/A	N/A

Summary

Astrana Health beats UL Solutions on 9 of the 16 factors compared between the two stocks.

Ad Deal Maker

The solution to fast food’s wage hike crisis

Shake Shack will be closing six California locations in response to the recent $20/hour minimum wage increase, according to the NY Post. With a sky-high 150% turnover rate, the fast food industry is already grappling with labor issues before taking into account these wage hikes. The industry will need a projected 1 million new workers every year through 2032.

Learn more about this much-needed advancement and investment opportunity here.

Get Astrana Health News Delivered to You Automatically

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ASTH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

ASTH vs. The Competition

Export to Excel

Metric	Astrana Health	Management consulting services Industry	Medical Sector	NASDAQ Exchange
Market Cap	$2.67B	$2.59B	$5.68B	$7.88B
Dividend Yield	N/A	2.42%	2.73%	4.02%
P/E Ratio	36.09	14.53	112.81	17.90
Price / Sales	1.68	30.99	1,778.72	79.14
Price / Cash	35.02	27.91	38.89	32.58
Price / Book	3.42	3.97	4.98	4.44
Net Income	$60.72M	$125.28M	$114.80M	$224.46M
7 Day Performance	-0.31%	-3.60%	-1.52%	-3.60%
1 Month Performance	2.76%	2.32%	8.47%	5.28%
1 Year Performance	N/A	44.89%	12.48%	4.44%

Astrana Health Competitors List

Export to Excel

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
ULS UL Solutions	1.3501 of 5 stars 1.35 / 5 stars	$50.52 -3.4%	$43.90 -13.1%	N/A	$10.10B	$2.68B	0.00	14,892	News Coverage Positive News
RDDT Reddit	2.1351 of 5 stars 2.14 / 5 stars	$58.90 +3.3%	$65.56 +11.3%	N/A	$9.77B	$804.03M	0.00	2,013	Insider Selling
STN Stantec	4.2293 of 5 stars 4.23 / 5 stars	$79.93 flat	$105.00 +31.4%	+17.4%	$9.12B	$6.91B	34.90	28,000	Positive News
CART Maplebear	4.6098 of 5 stars 4.61 / 5 stars	$34.08 +1.3%	$42.81 +25.6%	N/A	$9.02B	$3.21B	0.00	3,380	Analyst Forecast Analyst Revision News Coverage Positive News
GLOB Globant	4.7908 of 5 stars 4.79 / 5 stars	$200.71 +0.5%	$221.42 +10.3%	-4.0%	$8.65B	$2.28B	52.68	29,150	Analyst Forecast
HQY HealthEquity	4.1281 of 5 stars 4.13 / 5 stars	$80.42 -2.7%	$103.83 +29.1%	+9.9%	$7.00B	$1.04B	87.41	3,150	Analyst Forecast Analyst Revision News Coverage
BILI Bilibili	2.544 of 5 stars 2.54 / 5 stars	$15.54 +3.4%	$16.91 +8.8%	-1.4%	$6.42B	$23.95B	-9.31	8,801	Analyst Forecast Options Volume
ETSY Etsy	4.4885 of 5 stars 4.49 / 5 stars	$54.07 -2.7%	$70.61 +30.6%	-26.9%	$6.32B	$2.77B	24.69	2,420	Analyst Forecast Analyst Revision
QXO QXO	1.8921 of 5 stars 1.89 / 5 stars	$13.71 +6.5%	N/A	N/A	$5.61B	$54.52M	-7.79	195
TNET TriNet Group	3.8693 of 5 stars 3.87 / 5 stars	$97.61 -2.2%	$118.40 +21.3%	-14.5%	$4.85B	$4.92B	16.00	3,600	Insider Selling News Coverage